Evidence map›Paper›PMID 42151326›Full record

ArticleScientific reports2026

Green-synthesized silver nanoparticles optimized by Taguchi method inhibit urease activity in antibiotic-resistant helicobacter pylori.

Reza Ghanbari, Alireza Yazdinezhad, Hossein Danafar, Shayan Asadi, Hafezeh Salehabadi

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Reza GhanbariDepartment of Medicinal Chemistry, School of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran.
Alireza YazdinezhadDepartment of Pharmacognosy and Traditional Pharmacy, School of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran.
Hossein DanafarDepartment of Medicinal Chemistry, School of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran.
Shayan AsadiDepartment of Medicinal Chemistry, School of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran.
Hafezeh SalehabadiDepartment of Medicinal Chemistry, School of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran. hsalehabadi@zums.ac.ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Helicobacter pylori (H. pylori) infection remains a significant global health challenge, contributing to various gastrointestinal disorders, including peptic ulcers and gastric cancer. The bacterium's urease enzyme plays a pivotal role in its survival by neutralizing gastric acidity, making urease inhibitors a promising therapeutic strategy. This study explores the green synthesis of silver nanoparticles (AgNPs) using Persian lime (Citrus latifolia T.) fruit extract as a reducing and stabilizing agent, optimized via the Taguchi method to achieve minimal particle size for enhanced bioactivity. Characterization techniques such as Fourier-transform infrared spectroscopy (FT-IR), dynamic light scattering (DLS), transmission electron microscopy (TEM), X-ray diffraction (XRD), and UV-Vis spectroscopy confirmed the formation of spherical AgNPs with an average size of 27.63 nm and a zeta potential of -13.8 mV, indicating good stability. The green synthesized AgNPs exhibited potent urease inhibitory activity, with an IC

Indexed as

Anti-Bacterial AgentsDrug Resistance, BacterialEnzyme InhibitorsHelicobacter pyloriMetal NanoparticlesSilverUreaseCitrusGreen Chemistry TechnologyParticle SizePlant ExtractsSpectroscopy, Fourier Transform InfraredAnti-Bacterial AgentsEnzyme InhibitorsPlant ExtractsSilverUreaseGreen SynthesisHelicobacter pyloriPersian Lime ExtractSilver NanoparticlesTaguchi OptimizationUrease Inhibition

Identifiers

PMID42151326
PMCPMC13381534

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.